Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Metronidazole Administered Intravaginally for the Treatment of Bacterial Vaginosis
TCTR20250218011Phase 4Not yet recruiting
- Sponsor
- Buriram Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Buriram Hospital. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on TCTR20250218011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250218011.